Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FbQbfg68_2t84CRHBoOlH4cEEnnI.uncropped.jpg&w=3840&q=75)
Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page
- CheckyesterdayChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check44 days agoChange DetectedThe study has expanded to include 12 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.3%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check64 days agoChange DetectedThe value of the publication has been updated to correct an error in the author list, with an erratum published in July 2020 to reflect the accurate authorship of the study on Tislelizumab in Chinese patients with advanced solid tumors.SummaryDifference0.1%
- Check65 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.